![Jin-Sook Jung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 9 M $ al 31/08/2026
Jin-Sook Jung currently works at Amicus Lex Co., Ltd., as President & Chief Executive Officer.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Rznomics Co., Ltd.
 Rznomics Co., Ltd. BiotechnologyHealth Technology Develops gene therapies for the treatment of cancer and genetic diseases 1,51 % | 10/07/2026 | 422.078 ( 1,51 % ) | 9 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Amicus Lex Co., Ltd.
 Amicus Lex Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides legal and professional services | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 1 |
|---|---|
Amicus Lex Co., Ltd.
Amicus Lex Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides legal and professional services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
